{"article_title": "FCA Whistleblowers Poised To Target Post-Employment Fraud", "article_keywords": ["galmines", "fraud", "target", "source", "whistleblowers", "postemployment", "took", "novartis", "fca", "york", "v", "swiss", "poised", "view"], "article_url": "http://www.law360.com/articles/631680/fca-whistleblowers-poised-to-target-post-employment-fraud", "article_text": "FCA Whistleblowers Poised To Target Post-Employment Fraud\n\nLaw360, New York (March 19, 2015, 3:13 PM ET) -- A new False Claims Act ruling against Novartis Pharmaceuticals Corp. in Pennsylvania federal court shows that whistleblowers will increasingly be able to target fraud that took place years after they left their jobs, attorneys say.\n\n\n\nThe decision last month in Galmines v. Novartis centered on whether Donald Galmines, a former sales consultant for the Swiss drugmaker, qualifies as an \"original source\" of his allegations of misconduct that he said continued through 2009, three years after he departed the company.\n\n\n\nU.S. District Judge Gene E.K. Pratter called...\n\nTo view the full article, register now.", "article_metadata": {"description": "A new False Claims Act ruling against Novartis Pharmaceuticals Corp. in Pennsylvania federal court shows that whistleblowers will increasingly be able to target fraud that took place years after they left their jobs, attorneys say.", "apple-itunes-app": "app-id=934560389, app-argument=law360://www.law360.com/articles/631680/fca-whistleblowers-poised-to-target-post-employment-fraud", "csrf-token": "MaOWP8tm5I6yCs+XOBIliKTulBLgTtkKCEK8MDCeIIwGLV+deGfaakQ/WykU778ddP5LGkUgwvNqmhCx3kaj1A==", "csrf-param": "authenticity_token", "og": {"url": "http://www.law360.com/articles/631680/fca-whistleblowers-poised-to-target-post-employment-fraud", "image": "https://www.law360.com/images/360.png", "type": "website", "title": "FCA Whistleblowers Poised To Target Post-Employment Fraud - Law360"}, "viewport": "width=device-width, initial-scale=1.0"}, "article_summary": "FCA Whistleblowers Poised To Target Post-Employment FraudLaw360, New York (March 19, 2015, 3:13 PM ET) -- A new False Claims Act ruling against Novartis Pharmaceuticals Corp. in Pennsylvania federal court shows that whistleblowers will increasingly be able to target fraud that took place years after they left their jobs, attorneys say.\nPratter called...To view the full article, register now.\nThe decision last month in Galmines v. Novartis centered on whether Donald Galmines, a former sales consultant for the Swiss drugmaker, qualifies as an \"original source\" of his allegations of misconduct that he said continued through 2009, three years after he departed the company.\nU.S. District Judge Gene E.K."}